| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:RAD51B-GPHN |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: RAD51B-GPHN | FusionPDB ID: 71744 | FusionGDB2.0 ID: 71744 | Hgene | Tgene | Gene symbol | RAD51B | GPHN | Gene ID | 5890 | 10243 |
| Gene name | RAD51 paralog B | gephyrin | |
| Synonyms | R51H2|RAD51L1|REC2 | GEPH|GPH|GPHRYN|HKPX1|MOCODC | |
| Cytomap | 14q24.1 | 14q23.3-q24.1 | |
| Type of gene | protein-coding | protein-coding | |
| Description | DNA repair protein RAD51 homolog 2RAD51 homolog BRecA-like proteinrecombination repair protein | gephyrin | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | O15315 | Q9NQX3 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000469165, ENST00000390683, ENST00000471583, ENST00000487270, ENST00000487861, ENST00000488612, | ENST00000315266, ENST00000478722, ENST00000544752, ENST00000305960, ENST00000459628, ENST00000543237, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 22 X 15 X 11=3630 | 42 X 51 X 15=32130 |
| # samples | 22 | 62 | |
| ** MAII score | log2(22/3630*10)=-4.04439411935845 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(62/32130*10)=-5.69550895508454 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: RAD51B [Title/Abstract] AND GPHN [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | RAD51B(68353921)-GPHN(67626132), # samples:6 GPHN(67243239)-RAD51B(68301797), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | GPHN-RAD51B seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. GPHN-RAD51B seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. RAD51B-GPHN seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RAD51B-GPHN seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. RAD51B-GPHN seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. RAD51B-GPHN seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | GPHN | GO:0032324 | molybdopterin cofactor biosynthetic process | 26613940 |
| Tgene | GPHN | GO:0097112 | gamma-aminobutyric acid receptor clustering | 26613940 |
| Fusion gene breakpoints across RAD51B (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across GPHN (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | LUSC | TCGA-43-A474-01A | RAD51B | chr14 | 68353921 | - | GPHN | chr14 | 67626132 | + |
| ChimerDB4 | LUSC | TCGA-43-A474-01A | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + |
| ChimerDB4 | LUSC | TCGA-43-A474 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + |
| ChimerDB4 | STAD | TCGA-IP-7968-01A | RAD51B | chr14 | 68353921 | - | GPHN | chr14 | 67626132 | + |
| ChimerDB4 | STAD | TCGA-IP-7968-01A | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000487861 | RAD51B | chr14 | 68353921 | + | ENST00000315266 | GPHN | chr14 | 67626132 | + | 2168 | 833 | 29 | 1306 | 425 |
| ENST00000487861 | RAD51B | chr14 | 68353921 | + | ENST00000478722 | GPHN | chr14 | 67626132 | + | 2173 | 833 | 29 | 1306 | 425 |
| ENST00000471583 | RAD51B | chr14 | 68353921 | + | ENST00000315266 | GPHN | chr14 | 67626132 | + | 2139 | 804 | 0 | 1277 | 425 |
| ENST00000471583 | RAD51B | chr14 | 68353921 | + | ENST00000478722 | GPHN | chr14 | 67626132 | + | 2144 | 804 | 0 | 1277 | 425 |
| ENST00000487270 | RAD51B | chr14 | 68353921 | + | ENST00000315266 | GPHN | chr14 | 67626132 | + | 2139 | 804 | 0 | 1277 | 425 |
| ENST00000487270 | RAD51B | chr14 | 68353921 | + | ENST00000478722 | GPHN | chr14 | 67626132 | + | 2144 | 804 | 0 | 1277 | 425 |
| ENST00000488612 | RAD51B | chr14 | 68353921 | + | ENST00000315266 | GPHN | chr14 | 67626132 | + | 2118 | 783 | 0 | 1256 | 418 |
| ENST00000488612 | RAD51B | chr14 | 68353921 | + | ENST00000478722 | GPHN | chr14 | 67626132 | + | 2123 | 783 | 0 | 1256 | 418 |
| ENST00000390683 | RAD51B | chr14 | 68353921 | + | ENST00000315266 | GPHN | chr14 | 67626132 | + | 2091 | 756 | 0 | 1229 | 409 |
| ENST00000390683 | RAD51B | chr14 | 68353921 | + | ENST00000478722 | GPHN | chr14 | 67626132 | + | 2096 | 756 | 0 | 1229 | 409 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000487861 | ENST00000315266 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + | 0.000402303 | 0.9995977 |
| ENST00000487861 | ENST00000478722 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + | 0.000389382 | 0.9996106 |
| ENST00000471583 | ENST00000315266 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + | 0.000410303 | 0.99958974 |
| ENST00000471583 | ENST00000478722 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + | 0.00039969 | 0.99960035 |
| ENST00000487270 | ENST00000315266 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + | 0.000410303 | 0.99958974 |
| ENST00000487270 | ENST00000478722 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + | 0.00039969 | 0.99960035 |
| ENST00000488612 | ENST00000315266 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + | 0.000436977 | 0.99956304 |
| ENST00000488612 | ENST00000478722 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + | 0.000423933 | 0.99957603 |
| ENST00000390683 | ENST00000315266 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + | 0.000406096 | 0.9995939 |
| ENST00000390683 | ENST00000478722 | RAD51B | chr14 | 68353921 | + | GPHN | chr14 | 67626132 | + | 0.000397363 | 0.9996026 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >71744_71744_1_RAD51B-GPHN_RAD51B_chr14_68353921_ENST00000390683_GPHN_chr14_67626132_ENST00000315266_length(amino acids)=409AA_BP=252 MGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQRSADFSPAFLSTTLSAL DEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYFNTEEKLLLTSSKVHLY RELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDYLKQVLDIDLHAQIHFG RVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLP -------------------------------------------------------------- >71744_71744_2_RAD51B-GPHN_RAD51B_chr14_68353921_ENST00000390683_GPHN_chr14_67626132_ENST00000478722_length(amino acids)=409AA_BP=252 MGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQRSADFSPAFLSTTLSAL DEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYFNTEEKLLLTSSKVHLY RELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDYLKQVLDIDLHAQIHFG RVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLP -------------------------------------------------------------- >71744_71744_3_RAD51B-GPHN_RAD51B_chr14_68353921_ENST00000471583_GPHN_chr14_67626132_ENST00000315266_length(amino acids)=425AA_BP=268 LCKGWGNLKVGCCRPGMGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQR SADFSPAFLSTTLSALDEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYF NTEEKLLLTSSKVHLYRELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDY LKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRP -------------------------------------------------------------- >71744_71744_4_RAD51B-GPHN_RAD51B_chr14_68353921_ENST00000471583_GPHN_chr14_67626132_ENST00000478722_length(amino acids)=425AA_BP=268 LCKGWGNLKVGCCRPGMGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQR SADFSPAFLSTTLSALDEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYF NTEEKLLLTSSKVHLYRELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDY LKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRP -------------------------------------------------------------- >71744_71744_5_RAD51B-GPHN_RAD51B_chr14_68353921_ENST00000487270_GPHN_chr14_67626132_ENST00000315266_length(amino acids)=425AA_BP=268 LCKGWGNLKVGCCRPGMGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQR SADFSPAFLSTTLSALDEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYF NTEEKLLLTSSKVHLYRELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDY LKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRP -------------------------------------------------------------- >71744_71744_6_RAD51B-GPHN_RAD51B_chr14_68353921_ENST00000487270_GPHN_chr14_67626132_ENST00000478722_length(amino acids)=425AA_BP=268 LCKGWGNLKVGCCRPGMGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQR SADFSPAFLSTTLSALDEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYF NTEEKLLLTSSKVHLYRELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDY LKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRP -------------------------------------------------------------- >71744_71744_7_RAD51B-GPHN_RAD51B_chr14_68353921_ENST00000487861_GPHN_chr14_67626132_ENST00000315266_length(amino acids)=425AA_BP=268 MCKGWGNLKVGCCRPGMGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQR SADFSPAFLSTTLSALDEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYF NTEEKLLLTSSKVHLYRELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDY LKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRP -------------------------------------------------------------- >71744_71744_8_RAD51B-GPHN_RAD51B_chr14_68353921_ENST00000487861_GPHN_chr14_67626132_ENST00000478722_length(amino acids)=425AA_BP=268 MCKGWGNLKVGCCRPGMGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQR SADFSPAFLSTTLSALDEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYF NTEEKLLLTSSKVHLYRELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDY LKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRP -------------------------------------------------------------- >71744_71744_9_RAD51B-GPHN_RAD51B_chr14_68353921_ENST00000488612_GPHN_chr14_67626132_ENST00000315266_length(amino acids)=418AA_BP=261 LKVGCCRPGMGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQRSADFSPA FLSTTLSALDEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYFNTEEKLL LTSSKVHLYRELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDYLKQVLDI DLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCIL -------------------------------------------------------------- >71744_71744_10_RAD51B-GPHN_RAD51B_chr14_68353921_ENST00000488612_GPHN_chr14_67626132_ENST00000478722_length(amino acids)=418AA_BP=261 LKVGCCRPGMGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQRSADFSPA FLSTTLSALDEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYFNTEEKLL LTSSKVHLYRELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDYLKQVLDI DLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCIL -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr14:68353921/chr14:67626132) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| RAD51B | GPHN |
| FUNCTION: Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA breaks arising during DNA replication or induced by DNA-damaging agents. May promote the assembly of presynaptic RAD51 nucleoprotein filaments. Binds single-stranded DNA and double-stranded DNA and has DNA-dependent ATPase activity. Part of the RAD21 paralog protein complex BCDX2 which acts in the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, BCDX2 acts downstream of BRCA2 recruitment and upstream of RAD51 recruitment. BCDX2 binds predominantly to the intersection of the four duplex arms of the Holliday junction and to junction of replication forks. The BCDX2 complex was originally reported to bind single-stranded DNA, single-stranded gaps in duplex DNA and specifically to nicks in duplex DNA. The BCDX2 subcomplex RAD51B:RAD51C exhibits single-stranded DNA-dependent ATPase activity suggesting an involvement in early stages of the HR pathway. {ECO:0000269|PubMed:11751635, ECO:0000269|PubMed:11751636, ECO:0000269|PubMed:11842113, ECO:0000269|PubMed:12441335, ECO:0000269|PubMed:23108668, ECO:0000269|PubMed:23149936}. | FUNCTION: Microtubule-associated protein involved in membrane protein-cytoskeleton interactions. It is thought to anchor the inhibitory glycine receptor (GLYR) to subsynaptic microtubules (By similarity). Acts as a major instructive molecule at inhibitory synapses, where it also clusters GABA type A receptors (PubMed:25025157, PubMed:26613940). {ECO:0000250|UniProtKB:Q03555, ECO:0000269|PubMed:25025157, ECO:0000269|PubMed:26613940}.; FUNCTION: Has also a catalytic activity and catalyzes two steps in the biosynthesis of the molybdenum cofactor. In the first step, molybdopterin is adenylated. Subsequently, molybdate is inserted into adenylated molybdopterin and AMP is released. {ECO:0000269|PubMed:26613940}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | RAD51B | chr14:68353921 | chr14:67626132 | ENST00000390683 | + | 6 | 10 | 108_115 | 252.0 | 367.0 | Nucleotide binding | ATP |
| Hgene | RAD51B | chr14:68353921 | chr14:67626132 | ENST00000471583 | + | 7 | 11 | 108_115 | 252.0 | 351.0 | Nucleotide binding | ATP |
| Hgene | RAD51B | chr14:68353921 | chr14:67626132 | ENST00000487270 | + | 7 | 11 | 108_115 | 252.0 | 385.0 | Nucleotide binding | ATP |
| Hgene | RAD51B | chr14:68353921 | chr14:67626132 | ENST00000488612 | + | 7 | 12 | 108_115 | 252.0 | 495.6666666666667 | Nucleotide binding | ATP |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | GPHN | chr14:68353921 | chr14:67626132 | ENST00000315266 | 16 | 22 | 14_166 | 579.0 | 737.0 | Region | Note=MPT Mo-transferase | |
| Tgene | GPHN | chr14:68353921 | chr14:67626132 | ENST00000315266 | 16 | 22 | 326_736 | 579.0 | 737.0 | Region | Note=MPT adenylyltransferase | |
| Tgene | GPHN | chr14:68353921 | chr14:67626132 | ENST00000478722 | 17 | 23 | 14_166 | 612.0 | 770.0 | Region | Note=MPT Mo-transferase | |
| Tgene | GPHN | chr14:68353921 | chr14:67626132 | ENST00000478722 | 17 | 23 | 326_736 | 612.0 | 770.0 | Region | Note=MPT adenylyltransferase |
Top |
Fusion Protein Structures |
| PDB and CIF files of the predicted fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
| Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
| PDB file >>>886_RAD51B_68353921_GPHN_67626132_886_RAD51B_68353921_GPHN_67626132_ranked_0.pdb | RAD51B | 68353921 | 68353921 | ENST00000478722 | GPHN | chr14 | 67626132 | + | MCKGWGNLKVGCCRPGMGSKKLKRVGLSQELCDRLSRHQILTCQDFLCLSPLELMKVTGLSYRGVHELLCMVSRACAPKMQTAYGIKAQR SADFSPAFLSTTLSALDEALHGGVACGSLTEITGPPGCGKTQFCIMMSILATLPTNMGGLEGAVVYIDTESAFSAERLVEIAESRFPRYF NTEEKLLLTSSKVHLYRELTCDEVLQRIESLEEEIISKGIKLVILDSVASVVRKEFDAQLQGNLKERNKFLAREASSLKYLAEEFSIPDY LKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRP | 425 |
Top |
pLDDT score distribution |
| pLDDT score distribution of the predicted wild-type structures of two partner proteins from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
RAD51B_pLDDT.png  |
GPHN_pLDDT.png  |
| pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
 |
Top |
Ramachandran Plot of Fusion Protein Structure |
| Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
| Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| RAD51B | RAD51, RAD51C, RAD51D, XRCC2, SWSAP1, FAM9B, DKKL1, ARL4C, MUC20, ADAMTS4, HELQ, HNRNPL, SPDL1, BRCA1, TPT1, ABL1, MEOX2, RPAIN, ANAPC5, BAGE2, C15orf39, PRPF6, C5orf34, N4BP2L2, BANP, ANKHD1-EIF4EBP3, KLRC2, DSCC1, SATB2, ZNHIT6, PMS1, NUF2, APAF1, PRKACB, MAPRE2, CD300LB, PRKACG, TBC1D2B, MTR, |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| RAD51B |  |
| GPHN |  |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Tgene | GPHN | chr14:68353921 | chr14:67626132 | ENST00000315266 | 16 | 22 | 140_316 | 579.0 | 737.0 | GABARAP | |
| Tgene | GPHN | chr14:68353921 | chr14:67626132 | ENST00000478722 | 17 | 23 | 140_316 | 612.0 | 770.0 | GABARAP |
Top |
Related Drugs to RAD51B-GPHN |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to RAD51B-GPHN |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | RAD51B | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
| Hgene | RAD51B | C0013146 | Drug abuse | 1 | CTD_human |
| Hgene | RAD51B | C0013170 | Drug habituation | 1 | CTD_human |
| Hgene | RAD51B | C0013222 | Drug Use Disorders | 1 | CTD_human |
| Hgene | RAD51B | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
| Hgene | RAD51B | C0038580 | Substance Dependence | 1 | CTD_human |
| Hgene | RAD51B | C0038586 | Substance Use Disorders | 1 | CTD_human |
| Hgene | RAD51B | C0236969 | Substance-Related Disorders | 1 | CTD_human |
| Hgene | RAD51B | C0238033 | Carcinoma of Male Breast | 1 | CTD_human |
| Hgene | RAD51B | C0242788 | Breast Neoplasms, Male | 1 | CTD_human |
| Hgene | RAD51B | C0678222 | Breast Carcinoma | 1 | CTD_human |
| Hgene | RAD51B | C0740858 | Substance abuse problem | 1 | CTD_human |
| Hgene | RAD51B | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| Hgene | RAD51B | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| Hgene | RAD51B | C1510472 | Drug Dependence | 1 | CTD_human |
| Hgene | RAD51B | C4316881 | Prescription Drug Abuse | 1 | CTD_human |
| Hgene | RAD51B | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
| Tgene | GPHN | C1854990 | Molybdenum Cofactor Deficiency, Complementation Group C | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Tgene | GPHN | C0001956 | Alcohol Use Disorder | 1 | CTD_human |
| Tgene | GPHN | C0001973 | Alcoholic Intoxication, Chronic | 1 | CTD_human |
| Tgene | GPHN | C0009171 | Cocaine Abuse | 1 | CTD_human |
| Tgene | GPHN | C0085762 | Alcohol abuse | 1 | CTD_human |
| Tgene | GPHN | C0236736 | Cocaine-Related Disorders | 1 | CTD_human |
| Tgene | GPHN | C0543888 | Epileptic encephalopathy | 1 | GENOMICS_ENGLAND |
| Tgene | GPHN | C0600427 | Cocaine Dependence | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies